Evolution of global drug market and amrket access

Evolution of global drug market and amrket access

Bibliographic Details
Main Author:	Mario Eandi
Format:	Article
Language:	English
Published:	SEEd Medical Publishers 2008-09-01
Series:	Farmeconomia: Health Economics and Therapeutic Pathways
Online Access:	https://journals.seedmedicalpublishers.com/index.php/FE/article/view/224

Similar Items

Poder e comunicação: a emergência do amrketing na política capixaba da década de oitenta (1980)
by: MACEDO, M. H. A.
Published: (2016)

Equity of access to innovative drugs and sustainability of pharmaceutical expenditure
by: Mario Eandi
Published: (2010-06-01)

Liberalization of OTC drugs market in Italy
by: Mario Eandi
Published: (2008-06-01)

Liberalization of drugs market in Italy and trends in OTC in Europe
by: Mario Eandi
Published: (2007-03-01)

New rules for the generic drugs market introduced by the "Decreto Abruzzi"
by: Mario Eandi
Published: (2009-03-01)

Prescription and use of “equivalent” drugs
by: Mario Eandi
Published: (2007-06-01)

New reimbursement criteria for lipid-lowering drugs
by: Mario Eandi
Published: (2011-06-01)

Growing impact of pharmacogenomic on drug development and personalized medicine
by: Mario Eandi
Published: (2008-01-01)

Rational and irrational factors in the dynamics of pharmaceutical expenditure and in the drug price negotiation
by: Mario Eandi
Published: (2006-09-01)

[Pegylated interferon beta-1a on the Italian market]
by: Mario Eandi
Published: (2016-07-01)

Global competition policy and market access
by: Burton, Andrew James
Published: (2009)

Global competition policy and market access
by: Burton, Andrew James
Published: (2009)

Industry perspectives on market access of innovative drugs
by: Kim ePauwels, et al.
Published: (2016-06-01)

OpenCourseWare, Global Access and the Right to Education: Real access or marketing ploy?
by: Henk Huijser, et al.
Published: (2008-02-01)

Drug repurposing and market access : conditions and determinants for price, reimbursement and access of reformulated and repositioned drugs in the United States of America and Europe
by: Do Monte Fialho Murteira, Susana Claudia
Published: (2014)

The Evolution of Foreign Exchange Markets in the Context of Global Crisis
by: Mariana Trandafir, et al.
Published: (2011-12-01)

Market access of orphan drugs and the role of multi-criteria decision making
by: Simoens Steven
Published: (2012-11-01)

ILLEGAL DRUG MARKETS IN EUROPE: THE NEGATIVE CONSEQUENCES OF GLOBALIZATION
by: Loredana Maftei
Published: (2012-06-01)

Intervening in global markets to improve access to HIV/AIDS treatment: an analysis of international policies and the dynamics of global antiretroviral medicines markets
by: Hochstadt Jenny, et al.
Published: (2010-05-01)

Evolution of antiretroviral drug costs in Brazil in the context of free and universal access to AIDS treatment.
by: Amy S Nunn, et al.
Published: (2007-11-01)

Costruzione di un modello decisionale per valutare la costo/efficacia delle strategie alternative nella terapia della polmonite acquisita in comunità
by: Mario Eandi
Published: (2001-03-01)

Analisi Costo-Efficacia di Amfotericina B Liposomiale (L-AmB) versus Amfotericina B Complesso Lipidico (ABLC) nel trattamento empirico della neutropenia febbrile
by: Mario Eandi
Published: (2005-12-01)

Il Rapporto nazionale 2004 sull’uso dei farmaci in Italia
by: Mario Eandi
Published: (2005-06-01)

European health information system and cardiovascular diseases
by: Mario Eandi
Published: (2006-03-01)

Regional control of pharmaceutical expenditure in the DL May 31, 2010 No 78
by: Mario Eandi
Published: (2010-03-01)

ALPRAZOLAM: profilo farmacoeconomico nei disturbi d’ansia e da attacchi di panico
by: Mario Eandi
Published: (2002-03-01)

Stato di salute degli italiani e prospettive di spesa sanitaria e farmaceutica
by: Mario Eandi
Published: (2000-06-01)

News from the 2007 financial act on pharmaceuticals
by: Mario Eandi
Published: (2006-01-01)

Razionalizzare la spesa ospedaliera: Day-Hospital, ADI, Hospice
by: Mario Eandi
Published: (2005-06-01)

Cost-effectiveness analysis of paclitaxel + carboplatin vs. alternative combinations in the treatment of non-small cell lung cancer
by: Mario Eandi
Published: (2006-09-01)

A changing journal in a changing health care
by: Mario Eandi
Published: (2012-03-01)

Theory and practice of the Health Technology Assessment in countries with a predominant public health service
by: Mario Eandi
Published: (2009-06-01)

News from the Italian "Finanziaria 2008" and related pharmaceutical expenditure
by: Mario Eandi
Published: (2008-03-01)

The trend of pharmaceutical expenditure in Italy: from the report OsMed 2013 to the monitoring 2014
by: Mario Eandi
Published: (2014-12-01)

Which future for pharmacoeconomics in Italy?
by: Mario Eandi
Published: (2007-06-01)

The pharmaceutical expenditure in Italy in 2009: toward regional federalism
by: Mario Eandi
Published: (2009-01-01)

Economic crisis and consumption of medical resources in Italy
by: Mario Eandi
Published: (2009-09-01)

Clinical and economic profile of entecavir in the treatment of chronic hepatitis b virus infection
by: Mario Eandi
Published: (2011-06-01)

The breakthrough of public pharmaceutical expenditure in 2005
by: Mario Eandi
Published: (2006-09-01)

Costo-efficacia dell’amfotericina B liposomiale nella terapia dell’aspergillosi invasiva
by: Mario Eandi
Published: (2004-03-01)